Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Brief Psychological Intervention to Reduce Alcohol Consumption

30 juni 2026 uppdaterad av: Emma Brown, Lancaster University
Continuous levels of hazardous alcohol consumption (i.e., 14 or more units per week) is one of the leading risk factors of ill health and early mortality, contributing to around 9,809 deaths a year in the UK. The aim of the present research is to test the effect of helping people to reward themselves when they have successfully reduced/abstained from their previous levels of alcohol consumption. Each participant will be randomly allocated to one of two conditions. The trial requires 128 participants to perform a fully powered statistical analysis. The two conditions include: (1) a control condition (asked to form a plan to reduce/abstain from alcohol consumption), or (2) a weekly self-incentivising condition (asked to reward themselves at the end of each week that they have successfully reduced/abstained their previous levels of alcohol consumption). The main outcome measure will be units of alcohol consumed/not consumed, which will be self-reported at 1-week and 1-month follow-up time points.

Studieöversikt

Status

Avslutad

Betingelser

Detaljerad beskrivning

The research aims to test the role of self-incentivising implementation intentions for reductions/abstinence of alcohol consumption among people aged 18 and over, residing in the UK, and consuming 14 units of more of alcohol at the start of the study. The effectiveness of self-incentives has been successfully seen previously within health behaviour change, has not been tested in reduction/abstinence of alcohol consumption. Therefore, this research will build on what is known about the effectiveness of self-incentives used for increasing fruit and vegetable consumption, and smoking cessation.

This study is a randomised controlled trial with the between participants factor of condition which has two levels:

1. Control (plan) or 2. Weekly self-incentivising implementation intention.

The within participants' factor will be time which has three levels:

Baseline (T1) Follow-up (T2) (1-week following baseline) Follow-up (T3) (1-month following baseline)

An ethical concern is that participants in the control condition may struggle more to reduce/abstain from alcohol consumption as they will not have the additional benefits of being within an experimental condition which uses self-incentives to aid their attempt. A control condition is needed to monitor if changes to alcohol consumption is due to the use of self-incentives or another behaviour change technique.

The recruitment process will recruit participants to complete an online questionnaire (via Qualtrics), from Prolific. Prolific is an online recruitment platform, which allows screeners to be set (e.g., age, residency, consumption level) prior to contacting potential participants. Prolific then contacts the participants to which the screeners apply, and the participants can decide if they would like to take part. The researcher can then set restrictions to only allow completion of the follow-up questionnaires, based on those participants who completed the online questionnaire at baseline.

All participants who are able to provide informed consent, are over the age of 18 years old, resident in the UK (due to discrepancies in the safe recommended alcohol consumption rates across countries), are eligible to take part in the study. Unfortunately, the study does not cater for people who cannot understand English at the present time, although this will be monitored for amendments in future studies.

The participant information sheet included prior to the online questionnaire includes details about the study, costs and benefits of taking part in the study, and the right to consent and withdraw at any point throughout the study. There are no risks involved in taking part in the study. Participants are reimbursed via Prolific based on the expected time to complete each questionnaire (i.e., £3.55 per questionnaire completed, which equates to more than the current UK living wage). There is a minimal burden in time taken to complete the questionnaires, which should take no longer than 15 minutes per time point, though this time estimation is considered generous.

In terms of confidentiality, participants will not provide any identifier other than their Prolific ID. This ensures that no identifying information is available to the research team, but that the participant can be added to the screener for completion of the baseline questionnaires, and that all questionnaires (baseline, 1-week follow-up, and 1-month follow-up) can be matched.

There are no conflicts of interest. Participants are provided with contact details of the research team, should they like to contact for a summary of the results.

Studietyp

Interventionell

Inskrivning (Faktisk)

228

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • Aged 18 years or over
  • Able to understand written English
  • Competent to provide informed consent
  • Residing in the UK
  • Regularly consuming 14 units of alcohol or more at baseline

Exclusion Criteria:

  • Note aged 18 years old or over
  • Not able to understand written English
  • Not competent to provide informed consent
  • Not residing in the UK
  • Not regularly consuming 14 units of alcohol or more at baseline

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Behavioural: Self-incentive
Weekly self-incentivising
Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption). Participants are then asked to specify a self-incentive on which they could implement at the end of each week which they have been successful.
Aktiv komparator: Plan
Control
Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption). Participants are then asked to form their plan.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Alcohol consumption
Tidsram: Up to 1-month
Total units of alcohol consumed in last week
Up to 1-month

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Alcohol use disorders identification test (AUDIT)
Tidsram: Up to 1- month
Changes in AUDIT scores
Up to 1- month
Compliance to self-incentivise
Tidsram: Up to 1-month
Whether participants allocated to the intervention self-incentives
Up to 1-month
Frequency of self-incentivisation
Tidsram: Up to 1-month
How frequently participants allocated to the intervention condition use self-incentives
Up to 1-month
Self-incentives used
Tidsram: Up to 1-month
What self-incentives are chosen by participants (monetary, BCT etc)
Up to 1-month

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

20 maj 2026

Primärt slutförande (Faktisk)

21 juni 2026

Avslutad studie (Faktisk)

21 juni 2026

Studieregistreringsdatum

Först inskickad

30 juni 2026

Först inskickad som uppfyllde QC-kriterierna

30 juni 2026

Första postat (Faktisk)

7 juli 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

7 juli 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

30 juni 2026

Senast verifierad

1 juni 2026

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • FHM-2024-4354-RECR-4

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

IPD-planbeskrivning

Data may be shared if this complies with ethical guidelines

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera